Revenue (Tables)

9 Months Ended

Sep. 30, 2022

Revenue [Abstract]

Schedule of Revenue by Major Customers by Reporting Segments

The Company provides orthopedic solutions, including products and services spanning the full continuum of patient care, from injury prevention to rehabilitation. Substantially all its revenue is recognized at a point in time. The Company disaggregates its revenue into the following segments:

	Three Months Ended				Nine Months Ended
	September 30, 2022		October 1, 2021		September 30, 2022		October 1, 2021
	(In thousands)
Prevention and Recovery	$	256,502	$	256,229	$	765,121	$	757,822
Reconstructive	127,312		103,694		389,267		269,308
Total	$	383,814	$	359,923	$	1,154,388	$	1,027,130

Financing Receivable, Allowance for Credit Loss

A summary of the activity in the Company’s allowance for credit losses included within Trade receivables in the Condensed Consolidated Balance Sheets is as follows:

	Nine Months Ended September 30, 2022
	Balance at Beginning of Period		Charged to Expense, net		Write-Offs, Deductions and Other, net		Foreign Currency Translation		Balance at End of Period
	(In thousands)
Allowance for credit losses	$	6,589	$	3,345	$	(2,027)	$	(391)	$	7,516